Source

Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole (Text with EEA relevance.)

Implementing Regulation (EU) 2019/707 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2020’; (2) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2020’; (3) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2020’; (4) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2020’; (5) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2020’; (6) in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2020’; (7) in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2020’; (8) in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2020’; (9) in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2020’; (10) in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2020’; (11) in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2020’; (12) in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2020’; (13) in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2020’; (14) in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2020’; (15) in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2020’; (16) in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2020’; (17) in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2020’; (18) in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2020’; (19) in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2020’; (20) in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2020’; (21) in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2020’; (22) in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2020’; (23) in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2020’; (24) in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2020’; (25) in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2020’; (26) in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2020’; (27) in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2020’; (28) in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2020’; (29) in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2020’; (30) in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2020’; (31) in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2020’; (32) in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2020’; (33) in the sixth column, expiration of approval, of row 192, Diuron, the date is replaced by ‘30 September 2020’; (34) in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘31 August 2020’.

Other acts of the same type

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

What to look at next

Browse all EU Legal ActsEvery instrument by type and year, full text free to read section by sectionEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year European Union: what this database coversWhich datasets are here, which official source they come from, and how current they areEuropean Union overview